Annovis' (ANVS) shares surge on the successful development of its lead candidate in Alzheimer's disease.
Eli Lilly (NYSE: LLY) is a top growth stock to own. Although Eli Lilly's payout doesn't look like anything to get excited about (it currently yields less than 1%), that's deceptively low. Over the years the pharmaceutical giant has also increased its dividend payments.
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.